Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kakurai

Showing results (91-100 of 100) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 100 results.
Nature Communications|January 10, 2024
Field-induced bound-state condensation and spin-nematic phase in SrCu<sub>2</sub>(BO<sub>3</sub>)<sub>2</sub> revealed by neutron scattering up to 25.9 TEllen Fogh, Mithilesh Nayak, Oleksandr Prokhnenko, et al.
Clinical and Translational Science|October 28, 2025
Effect of Valemetostat on the Pharmacokinetics of Midazolam and Digoxin: A Phase 1 Drug-Drug Interaction Study in Patients With Non-Hodgkin LymphomaMasaya Tachibana, Steven Horwitz, Eric Jacobsen, et al.
Neuro-Oncology|November 9, 2025
Phase II study of safusidenib erbumine in patients with chemotherapy- and radiotherapy-naïve isocitrate dehydrogenase 1-mutated WHO grade 2 gliomasYoshiki Arakawa, Ryuta Saito, Yonehiro Kanemura, et al.
Nature Communications|March 7, 2019
Topological transitions among skyrmion- and hedgehog-lattice states in cubic chiral magnetsY Fujishiro, N Kanazawa, T Nakajima, et al.
Journal of Physics. Condensed Matter : an Institute of Physics Journal|February 1, 2017
Spin glass behavior in frustrated quantum spin system CuAl<sub>2</sub>O<sub>4</sub> with a possible orbital liquid stateR Nirmala, Kwang-Hyun Jang, Hasung Sim, et al.
International Journal of Clinical Oncology|October 2, 2021
Phase 2 study of axicabtagene ciloleucel in Japanese patients with relapsed or refractory large B-cell lymphomaKoji Kato, Shinichi Makita, Hideki Goto, et al.
International Journal of Hematology|November 18, 2022
A phase 2 study of axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma in Japan: 1-year follow-up and biomarker analysisKoji Kato, Nobuharu Fujii, Shinichi Makita, et al.
Blood|September 23, 2022
An open-label, single-arm phase 2 trial of valemetostat for relapsed or refractory adult T-cell leukemia/lymphomaKoji Izutsu, Shinichi Makita, Kisato Nosaka, et al.
Neuro-Oncology|June 20, 2022
The first-in-human phase I study of a brain-penetrant mutant IDH1 inhibitor DS-1001 in patients with recurrent or progressive IDH1-mutant gliomasAtsushi Natsume, Yoshiki Arakawa, Yoshitaka Narita, et al.
The Lancet. Oncology|November 1, 2024
Valemetostat monotherapy in patients with relapsed or refractory non-Hodgkin lymphoma: a first-in-human, multicentre, open-label, single-arm, phase 1 studyDai Maruyama, Eric Jacobsen, Pierluigi Porcu, et al.
Pageof 10

Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
Nature Communications|January 10, 2024
Field-induced bound-state condensation and spin-nematic phase in SrCu<sub>2</sub>(BO<sub>3</sub>)<sub>2</sub> revealed by neutron scattering up to 25.9 TEllen Fogh, Mithilesh Nayak, Oleksandr Prokhnenko, et al.
Clinical and Translational Science|October 28, 2025
Effect of Valemetostat on the Pharmacokinetics of Midazolam and Digoxin: A Phase 1 Drug-Drug Interaction Study in Patients With Non-Hodgkin LymphomaMasaya Tachibana, Steven Horwitz, Eric Jacobsen, et al.
Neuro-Oncology|November 9, 2025
Phase II study of safusidenib erbumine in patients with chemotherapy- and radiotherapy-naïve isocitrate dehydrogenase 1-mutated WHO grade 2 gliomasYoshiki Arakawa, Ryuta Saito, Yonehiro Kanemura, et al.
Nature Communications|March 7, 2019
Topological transitions among skyrmion- and hedgehog-lattice states in cubic chiral magnetsY Fujishiro, N Kanazawa, T Nakajima, et al.
Journal of Physics. Condensed Matter : an Institute of Physics Journal|February 1, 2017
Spin glass behavior in frustrated quantum spin system CuAl<sub>2</sub>O<sub>4</sub> with a possible orbital liquid stateR Nirmala, Kwang-Hyun Jang, Hasung Sim, et al.
International Journal of Clinical Oncology|October 2, 2021
Phase 2 study of axicabtagene ciloleucel in Japanese patients with relapsed or refractory large B-cell lymphomaKoji Kato, Shinichi Makita, Hideki Goto, et al.
International Journal of Hematology|November 18, 2022
A phase 2 study of axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma in Japan: 1-year follow-up and biomarker analysisKoji Kato, Nobuharu Fujii, Shinichi Makita, et al.
Blood|September 23, 2022
An open-label, single-arm phase 2 trial of valemetostat for relapsed or refractory adult T-cell leukemia/lymphomaKoji Izutsu, Shinichi Makita, Kisato Nosaka, et al.
Neuro-Oncology|June 20, 2022
The first-in-human phase I study of a brain-penetrant mutant IDH1 inhibitor DS-1001 in patients with recurrent or progressive IDH1-mutant gliomasAtsushi Natsume, Yoshiki Arakawa, Yoshitaka Narita, et al.
The Lancet. Oncology|November 1, 2024
Valemetostat monotherapy in patients with relapsed or refractory non-Hodgkin lymphoma: a first-in-human, multicentre, open-label, single-arm, phase 1 studyDai Maruyama, Eric Jacobsen, Pierluigi Porcu, et al.
Pageof 10